Use of Ayurvedic Medicines in skin disease

RANDOMISED CONTROLLED CLINICAL STUDY OF AROGYAMISHRAN AND TANKANAMISHRAN IN DADRU W.S.R. TO TINEA

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/02/040587

Enrollment

120

Registered

2022-02-24

Start date

Unknown

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having the clinical features of dadru. Patients ready to abide trial procedure to give informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients aged below 14 & above 60 years. 2. Pregnant women & lactating mothers. 3. Patient of other skin disease like psoriasis, seborrhic dermatitis, lichen simplex, chronicus, pityriasis versicolor, eczema, candidiasis. 4. Patients having any known severe systemic diseases of renal, hepatic cardiac disorders, diabeties mellitus, tuberculosis, immuno deficiency syndrome, leprosy, malignant disease. 5.Patients having known drug allergy of sulphur, mercury.

Design outcomes

Primary

Measure	Time frame
Cure of Dadru kushta signs and symptoms Kandu (Pruritus) Raga (Erythema) Number of Mandala Size of MandalaTimepoint: 2 months	—

Secondary

Measure	Time frame
no recurrence of DadruTimepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDr Suryakiran Parashuram Wagh

Parul University Vadodara Gujarat

suryakiran_wagh@rediffmail.com09822846910

Outcome results